ULURU Inc. is a pharmaceutical company, which engages in the development and commercialization of wound care and muco-adhesive film products. It operates through Nanoflex Technology: Altrazeal and Transmucosal Drug Delivery: OraDisc. The company was founded in 1987 and is headquartered in Addison, TX.
Company profile
Website
CEO
Vaidehi Shah
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
ULURU Inc., ULURU INC., OXFORD VENTURES INC
SEC CIK
Corporate docs
IRS number
412118656
Latest filings (excl ownership)
D
$6.60 mm in equity, sold $2.22 mm, 2 investors
18 Sep 23
D
$8M in equity, sold $690K, 4 investors
25 Nov 19
EFFECT
Notice of effectiveness
6 Mar 19
EFFECT
Notice of effectiveness
6 Mar 19
EFFECT
Notice of effectiveness
6 Mar 19
EFFECT
Notice of effectiveness
6 Mar 19
15-12G
Securities registration termination
1 Mar 19
S-8 POS
Registration of securities for employees (post-effective amendment)
1 Mar 19
S-8 POS
Registration of securities for employees (post-effective amendment)
1 Mar 19
S-8 POS
Registration of securities for employees (post-effective amendment)
1 Mar 19
Latest ownership filings
SC 13D/A
ULURU Inc.
13 Apr 17
SC 13D/A
ULURU Inc.
13 Apr 17
SC 13D
ULURU Inc.
11 Apr 17
3
Arindam Bose
10 Apr 17
3
Anish Vithaldas Shah
10 Apr 17
3
Oksana Tiedt
10 Apr 17
3
Initial statement of insider ownership
10 Apr 17
3
Initial statement of insider ownership
10 Apr 17
4
Change in insider ownership
10 Apr 17
4/A
Vaidehi Shah
5 Apr 17
Institutional ownership, Q3 2019
| 13F holders | Current |
|---|---|
| Total holders | 0 |
| Opened positions | 0 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 0.00 |
| Total shares | 0.00 |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|